Rare diseases
Investigational molecules
Locations
Back to Latvia7 clinical trials in Jelgava, Latvia. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in LatviaKliniskiePetijumi.lv(opens in a new tab)LatviaLatviaLatviaLatviaLatviaLatviaLatviaThe busiest research cities in the country
What the registry says about research in the country
Clinical investigations focusing on type 2 diabetes management through combination therapy approaches. Research evaluates the effectiveness of gliclazide MR when combined with existing treatments.
Studies aim to improve blood sugar control in patients not achieving optimal results with current medications.
Groundbreaking research examining the impact of semaglutide on diabetic retinopathy in patients with type 2 diabetes. This long-term safety study evaluates treatment effects on eye health.
The research includes standardized ophthalmic evaluations to monitor disease progression and treatment outcomes.
Post-authorization safety assessments conducted under European Medicines Agency oversight, focusing on long-term effects of diabetes treatments.
These studies contribute to understanding the complete safety profile of new diabetes medications.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
